Autologous blood stem cell transplantation (ABSCT) in high-risk myeloma (MM)

Bone Marrow Transplant. 1991:7 Suppl 2:29.
No abstract available

MeSH terms

  • Adult
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Leukapheresis
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / therapy*
  • Remission Induction
  • Risk Factors
  • Transplantation, Autologous

Substances

  • Cyclophosphamide
  • Melphalan